Mark Froimson

PCRX

Mark Froimson serves as director at Pacira BioSciences, Inc. (PCRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$16.2K

Total Sells

3 trades

$123.3K

Net Position

Net Seller

$107.1K

Companies Traded

PCRX

Active Period

Mar 2021 – Mar 2026

4 total trades

Most Recent

Sell PCRX

Mar 19, 2026 · $10.9K

Mark Froimson's Insider Trading at Pacira BioSciences, Inc. (PCRX)

Buys

1 · $16.2K

Sells

3 · $123.3K

Total Shares Bought

1,400

Total Shares Sold

2,234

PCRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 19, 2026	Sell	500	$21.81	$10.9K	20,136
Aug 12, 2024	Buy	1,400	$11.58	$16.2K	14,473
May 11, 2022	Sell	1,000	$59.37	$59.4K	4,908
Mar 17, 2021	Sell	734	$72.26	$53.0K	5,242

Related Insiders

Shawn Cross

officer: Chief Financial Officer

PCRXSell · Apr 24, 2026

SLONIN JONATHAN

officer: Chief Medical Officer

PCRXSell · Mar 19, 2026

RIKER LAUREN

Senior Vice President, Finance

PCRXSell · Feb 3, 2026

Brendan Teehan

Chief Commercial Officer

PCRXSell · Jan 30, 2026

WILLIAMS KRISTEN

Chief Administrative Officer

PCRXSell · Jan 30, 2026

Frank D. Lee

Chief Executive Officer

PCRXSell · Jan 2, 2026

BIGAL MARCELO

Director

PCRXSell · Aug 7, 2025

Explore More Insider Trading Data

PCRX Insider Trading Activity

View all insider trades at Pacira BioSciences, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity